QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 16, Issue 4, 2119-2127, April 2005

This Article Full Text Full Text (PDF) All Versions of this Article: E04-09-0797v1 16/4/2119    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zheng, Y. Articles by Jiang, Y. Search for Related Content PubMed PubMed Citation Articles by Zheng, Y. Articles by Jiang, Y.

The Yeast Phosphotyrosyl Phosphatase Activator Is Part of the Tap42–Phosphatase Complexes

Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213

Submitted September 10, 2004; Accepted January 24, 2005
Monitoring Editor: Carl-Henrik Heldin

Phosphotyrosyl phosphatase activator PTPA is a type 2A phosphatase regulatory protein that possesses an ability to stimulate the phosphotyrosyl phosphatase activity of PP2A in vitro. In yeast Saccharomyces cerevisiae, PTPA is encoded by two related genes, RRD1 and RRD2, whose products are 38 and 37% identical, respectively, to the mammalian PTPA. Inactivation of either gene renders yeast cells rapamycin resistant. In this study, we investigate the mechanism underling rapamycin resistance associated with inactivation of PTPA in yeast. We show that the yeast PTPA is an integral part of the Tap42–phosphatase complexes that act downstream of the Tor proteins, the target of rapamycin. We demonstrate a specific interaction of Rrd1 with the Tap42–Sit4 complex and that of Rrd2 with the Tap42–PP2Ac complex. A small portion of PTPA also is found to be associated with the AC dimeric core of PP2A, but the amount is significantly less than that associated with the Tap42-containing complexes. In addition, our results show that the association of PTPA with Tap42–phosphatase complexes is rapamycin sensitive, and importantly, that rapamycin treatment results in release of the PTPA-phosphatase dimer as a functional phosphatase unit.

Address correspondence to: Yu Jiang (jiang{at}server.pharm.pitt.edu).

This article has been cited by other articles:

				J. C. Rutherford, G. Chua, T. Hughes, M. E. Cardenas, and J. Heitman A Mep2-dependent Transcriptional Profile Links Permease Function to Gene Expression during Pseudohyphal Growth in Saccharomyces cerevisiae Mol. Biol. Cell, July 1, 2008; 19(7): 3028 - 3039. [Abstract] [Full Text] [PDF]

				A. Magnusdottir, P. Stenmark, S. Flodin, T. Nyman, M. Hammarstrom, M. Ehn, M A. Bakali H, H. Berglund, and P. Nordlund The Crystal Structure of a Human PP2A Phosphatase Activator Reveals a Novel Fold and Highly Conserved Cleft Implicated in Protein-Protein Interactions J. Biol. Chem., August 11, 2006; 281(32): 22434 - 22438. [Abstract] [Full Text] [PDF]

				J. Douville, J. David, K. M. Lemieux, L. Gaudreau, and D. Ramotar The Saccharomyces cerevisiae Phosphatase Activator RRD1 Is Required to Modulate Gene Expression in Response to Rapamycin Exposure Genetics, February 1, 2006; 172(2): 1369 - 1372. [Abstract] [Full Text] [PDF]

				J. J. Tate, R. Rai, and T. G. Cooper Methionine Sulfoximine Treatment and Carbon Starvation Elicit Snf1-independent Phosphorylation of the Transcription Activator Gln3 in Saccharomyces cerevisiae J. Biol. Chem., July 22, 2005; 280(29): 27195 - 27204. [Abstract] [Full Text] [PDF]